Target intelligence / Profile preview

Cell membranes and endocytic machinery of antigen-presenting cells and myocytes

Molecular classification
Cellular structure, Endocytic pathway, Other
01

Overview

The term refers to the collective cellular structures and pathways responsible for the internalization of therapeutic agents, particularly lipid nanoparticles (LNPs) and nucleic acid-based drugs. This is not a single molecular entity but a complex system involving the lipid bilayer and various proteins involved in endocytic routes such as macropinocytosis, clathrin-mediated endocytosis, and caveolae-mediated endocytosis (Sahin et al., 2020, Nature Reviews Drug Discovery). In the context of mRNA vaccines, myocytes at the injection site and professional antigen-presenting cells (APCs), such as dendritic cells and macrophages, utilize this machinery to engulf the delivery vehicle. Once internalized, the cargo must achieve endosomal escape to reach the cytosol for translation into functional proteins (Pardi et al., 2018, Nature Reviews Drug Discovery). This process is critical for the pharmacokinetics and pharmacodynamics of modern genetic medicines, as it dictates the efficiency of antigen production and the subsequent activation of the adaptive immune system.

Other names
Cellular uptake machineryEndocytic pathway of APCs and muscle cellsLNP internalization system
02

Mechanism of action

Endocytosis-mediated cellular uptake followed by endosomal escape and cytosolic delivery of cargo.

03

Biological functions

EndocytosisAntigen presentationCellular uptakeProtein synthesisImmune response induction
04

Disease associations

Infection (Prophylaxis)Cancer (Immunotherapy)Genetic disorders
05

Safety considerations

LNP-induced reactogenicityInjection site inflammationHypersensitivity reactionsEndosomal sequestration of cargo
06

Interacting drugs

Tozinameran (Comirnaty)

3 more in the full profile.

07

Biomarkers

CD80/CD86 expression (APC activation)MHC class I and II expressionCytokine profiles (e.g., IFN-gamma, IL-6)

Beyond the preview

Go deeper on Cell membranes and endocytic machinery of antigen-presenting cells and myocytes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell membranes and endocytic machinery of antigen-presenting cells and myocytes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call